AI Pathology Breakthrough: Roche’s Lung Cancer Diagnostic Makes FDA History
In April 2025, Roche’s Ventana TROP2 (EPR20043) RxDx test became the first AI-powered diagnostic to receive FDA Breakthrough Device Designation. The device pairs an immunohistochemistry stain for TROP2 with a digital pathology